Clinical Electrophysiology -> Atrial Fibrillation & Atrial Flutter: -> Left Atrial Appendage Closure
D-AB28 - Left Atrial Appendage Closure- Trials and Tribulations (ID 32)
Abstract Plus
D-AB28-01 - Indications For Watchman Left Atrial Appendage Occlusion In The United States: Results From The National Cardiovascular Data Registry - Left Atrial Appendage Occlusion Registry (ID 808)
Abstract
Background: The indications for left atrial appendage occlusion (LAAO) with the WATCHMAN device in a real-world setting across the United States have not previously been reported.
Objective: To characterize patients who have undergone WATCHMAN implantation and describe indications for the procedure in clinical practice in the United States
Methods: We studied the clinical characteristics and procedural indications of 35,568 patients in the NCDR LAAO Registry undergoing WATCHMAN implantation between January 1, 2016 and December 31, 2018.
Results: The mean patient age was 76 ± 8.1 years; 92.6% were white and 58.9% were male. The mean CHA2DS2-VASc score was 4.8 ± 1.5, while mean HAS-BLED score was 3.0 ± 1.1. Prior stroke or TIA was reported in 39.8% of patients. The most commonly documented indications included increased thromboembolic risk (65.0%), history of major bleed (64.2%), high fall risk (35.5%), and patient preference (34.0%) [Figure 1A]. The most commonly cited types of bleeding history were gastrointestinal (41.7%), intracranial (11.8%), and other clinically relevant bleeding (15.0%) [Figure 1B]. Most of the population (72.1%) had at least two indications for the WATCHMAN, while 31.0% had three or more indications.
Conclusion: Among patients in the NCDR LAAO Registry, the mean CHA2DS2-VASc score was high, with a considerable portion of patients having had prior stroke or TIA. The most common indications for WATCHMAN implantation were increased thromboembolic risk, history of GI bleed, and high fall risk.
Collapse
Objective: To characterize patients who have undergone WATCHMAN implantation and describe indications for the procedure in clinical practice in the United States
Methods: We studied the clinical characteristics and procedural indications of 35,568 patients in the NCDR LAAO Registry undergoing WATCHMAN implantation between January 1, 2016 and December 31, 2018.
Results: The mean patient age was 76 ± 8.1 years; 92.6% were white and 58.9% were male. The mean CHA2DS2-VASc score was 4.8 ± 1.5, while mean HAS-BLED score was 3.0 ± 1.1. Prior stroke or TIA was reported in 39.8% of patients. The most commonly documented indications included increased thromboembolic risk (65.0%), history of major bleed (64.2%), high fall risk (35.5%), and patient preference (34.0%) [Figure 1A]. The most commonly cited types of bleeding history were gastrointestinal (41.7%), intracranial (11.8%), and other clinically relevant bleeding (15.0%) [Figure 1B]. Most of the population (72.1%) had at least two indications for the WATCHMAN, while 31.0% had three or more indications.
Conclusion: Among patients in the NCDR LAAO Registry, the mean CHA2DS2-VASc score was high, with a considerable portion of patients having had prior stroke or TIA. The most common indications for WATCHMAN implantation were increased thromboembolic risk, history of GI bleed, and high fall risk.
